Patients who used a digital-based strategy for evidence-based asthma control experienced modest improvements in medication adherence with lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.
During the INCA Sun trial, adults with asthma used reliever and preventer medicines outfitted with the Inhaler Compliance Assessment (INCA) device. Patients in the intervention group participated in educational and treatment-adjustment visits, whereas those in the control group received a standardized educational program.
Compared with baseline, 14% of the